Ausgabe 7/2016
Inhalt (14 Artikel)
Targeting the microenvironment of pancreatic cancer: overcoming treatment barriers and improving local immune responses
J. Strauss, C. Alewine, W. D. Figg, A. Duffy
Further evidence for preoperative chemoradiotherapy and transanal endoscopic surgery (TEM) in T2-3s,N0,M0 rectal cancer
C. Pericay, X. Serra-Aracil, J. Ocaña-Rojas, L. Mora-López, E. Dotor, A. Casalots, A. Pisa, E. Saigí
S-l combined with cisplatin plus concurrent chemoradiotherapy versus cisplatin plus concurrent chemoradiotherapy for Chinese patients with advanced gastric cancer: a multi-centre randomized controlled trial
X. Chen, W. Li, L. Sun, Y. Liu, S. Liu, R. Ma
Compliance to radiation therapy of head and neck cancer patients and impact on treatment outcome
B. C. Ferreira, P. Sá-Couto, M. C. Lopes, L. Khouri
A meta-analysis of abnormal β-catenin immunohistochemical expression as a prognostic factor in lung cancer: location is more important
Y. Yang, J. Shen, Jiaxi He, Jianxing He, G. Jiang
Can tumor regression grade influence survival outcome in ypT3 rectal cancer?
L. Shen, L. Wang, G. Li, H. Zhang, L. Liang, M. Fan, Y. Wu, W. Deng, W. Sheng, J. Zhu, Z. Zhang
CCR6 overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer
X. G. Zhang, B. T. Song, F. J. Liu, D. Sun, K. X. Wang, H. Qu
Landscape of early clinical trials for childhood and adolescence cancer in Spain
F. Bautista, S. Gallego, A. Cañete, J. Mora, C. Diaz de Heredia, O. Cruz, J. M. Fernández, S. Rives, L. Madero, V. Castel, M. E. Cela, G. Ramírez, C. Sábado, T. Acha, I. Astigarraga, A. Sastre, A. Muñoz, M. Guibelalde, L. Moreno
Clinical significance of cellular and acellular mucin pools in rectal carcinoma following preoperative chemoradiotherapy
J. A. Cienfuegos, J. Baixauli, F. Rotellar, J. Arredondo, J. J. Sola, L. Arbea, C. Pastor, J. L. Hernández-Lizoáin
Overexpression of Cathepsin L is associated with gefitinib resistance in non-small cell lung cancer
F. Cui, W. Wang, D. Wu, X. He, J. Wu, M. Wang
Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients
P. Yadav, M. Masroor, K. Tanwer, R. Mir, J. Javid, I. Ahmad, M. Zuberi, R. C. M. Kaza, S. K. Jain, N. Khurana, P. C. Ray, A. Saxena
Clinical significance of ECT2 expression in tissue and serum of gastric cancer patients
H.-B. Wang, H.-C. Yan, Y. Liu
Stereotactic body radiation therapy (SBRT) delays the emergence of castration resistance in patients with oligometastatic prostate cancer
M. I. Martínez-Fernández, J. L. Pérez Gracia, I. Gil-Bazo, R. Martínez-Monge